468
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Type‐2 diabetes down‐regulates glucose transporter proteins and genes of the human blood leukocytes

, , , &
Pages 350-358 | Received 13 Aug 2008, Accepted 11 Nov 2008, Published online: 08 Jul 2009

References

  • Zimmet P., Alberti K. G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782–7
  • Ruderman N., Williamson J. R., Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992; 6: 2905–14
  • Pugliese G., Tilton R. G., Williamson J. R. Glucose‐induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1991; 7: 35–59
  • Smitherman K. O., Peacock J. E. Infectious emergencies in patients with diabetes mellitus. Inf Dis Clin N Am 1995; 9: 53–77
  • Pereira M. A., Sannomiya P., Leme J. G. Inhibition of leukocyte chemotaxis by factor in alloxan‐induced diabetic rat plasma. Diabetes 1987; 36: 1307–14
  • Mowat A. G., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621–7
  • Tan J. S., Anderson J. L., Watanakunakorn C., Phair J. P. Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med 1975; 85: 26–33
  • Nolan C. M., Beaty H. N., Bagdade J. D. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978; 27: 89–894
  • Segal M. L., Fertel R. H., Kraut E. H., Sagone A. L. The role of reactive oxygen species in thromboxane b2 generation by polymorphonuclear leukocytes. J Lab Clin Med 1983; 102: 788–94
  • Greiner E. F., Guppy M., Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem 1994; 269: 484–90
  • Tollefsbol T. O., Cohen H. J. Culture kinetics of glycolytic enzyme induction, glucose utilization, and thymidine incorporation of extended‐exposure phytohemagglutinin‐stimulated human lymphocytes. J Cell Physiol 1985; 122: 98–104
  • Calder P. C. Fuel utilization by cells of the immune system. Proc Nutr Soc 1995; 54: 65–82
  • Newsholme P., Gordon S., Newsholme E. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 1987; 242: 631–6
  • Pithon‐Curi T. C., De Melo M. P., Curi R. Glucose and glutamine utilization by rat lymphocytes, monocytes and neutrophils in culture: a comparative study. Cell Biochem Funct 2004; 22: 321–6
  • Furukawa S., Saito H., Matsuda T., Inoue T., Fukatsu K., Han I., Hidemura A., Muto T. Relative effects of glucose and glutamine on reactive oxygen intermediate production by neutrophils. Shock 2000; 13: 274–8
  • Joost H. G., Bell G. I., Best J. D., Birnbaum M. J., Charron M. J., Chen Y. T., Doege H., James D. E., Lodish H. F., Moley K. H., Moley J. F., Mueckler M., Rogers S., Schürmann A., Seino S., Thorens B. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 2002; 282: E974–6
  • Hu X. J., Peng F., Zhou H. Q., Zhang Z. H., Cheng W. Y., Feng H. F. The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients. Biochim Biophys Acta 2000; 1466: 306–14
  • Estrada D. E., Elliott E., Zinman B. Regulation of glucose transport and expression of GLUT 3 transporters in human circulating mononuclear cells: studies in cells from insulin‐dependent diabetic and nondiabetic individuals. Metab Clin Exp 1994; 43: 591–8
  • Pia˛tkiewicz P., Czech A., Tatoń J. Glucose transport in human peripheral blood lymphocytes influenced by type 2 diabetes mellitus. Arch Immunol Ther Exp 2007; 55: 119–26
  • Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75
  • Hahn D., Blaschitz A., Korgun E. T., Lang I., Desoye G., Skofitsch G., Dohr G. From maternal glucose to fetal glycogen: expression of key regulators in the human placenta. Mol Hum Reprod 2001; 7: 1173–8
  • Korgun E. T., Demir R., Sedlmayr P., Desoye G., Arıkan G., Puerstner P., Haeusler M., Dohr G., Skofitsch G., Hahn T. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002; 28: 152–9
  • Korgun E. T., Demir R., Sedlmayr P., Desoye G., Arıkan G., Puerstner P., Haeusler M., Dohr G., Skofitsch G., Hahn T. Physiological leukocytosis during pregnancy is associated with changes in glucose transporter expression of maternal peripheral blood granulocytes and monocytes. Am J Reprod Immunol 2002; 45: 110–16
  • Dimitriadis G., Maratou E., Boutati E., Psarra K., Papasteriades C., Raptis A. S. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry A 2005; 64: 27–33
  • Kelley J. L., Rosek M. M., Suenram C. A., Schwartz C. J. Activation of human blood monocytes by adherence to tissue culture plastic surfaces. Exp Mol Pathol 1987; 46: 266–78
  • Fu Y., Maianu L., Melbert B. R., Garvey W. T. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004; 32: 182–90
  • Maratou E., Dimitriadis G., Kollias A., Boutati E., Lambadiari V. P., Mitrou P., Raptis S. A. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest 2007; 37: 282–90
  • Gould G. W., Holman G. D. The glucose transporter family: structure, function and tissue‐specific expression. Biochem J 1993; 295: 329–41
  • Beck‐Nielsen H., Pedersen O., Kragballe K., Sorensen N. S. The monocyte as a model for the study of insulin receptors in man. Diabetologia 1977; 13: 563–9
  • Rinaudo M. T., Curto M., Rabbone I., Piccinini S., Gamba S. Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non‐insulin‐dependent diabetes mellitus (NIDDM). J Diabet Compl 1994; 8: 221–5
  • Bagdade J. D., Stewart M., Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27: 677–81
  • Kaneshige H., Endoh M., Tomino Y., Nomoto Y., Sakai H., Arimori S. Impaired granulocyte function in patients with diabetes mellitus. Tokaj J Exp Clin Med 1982; 7: 77–80
  • Seidell J. Obesity, insulin resistance and diabetes: a worldwide epidemic. Br J Nutr 2000; 83: 5–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.